{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:35:48Z","timestamp":1792460148679,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.gene.2021.145967","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T01:46:18Z","timestamp":1631583978000},"page":"145967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Genetic analysis of 76 Spanish Pompe disease patients: Identification of 12 novel pathogenic GAA variants and functional characterization of splicing variants"],"prefix":"10.1016","volume":"808","author":[{"given":"Cinthia","family":"Ami\u00f1oso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3132-3614","authenticated-orcid":false,"given":"Jes\u00fas","family":"Solera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.gene.2021.145967_b0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"issue":"D1","key":"10.1016\/j.gene.2021.145967_b0010","doi-asserted-by":"crossref","first-page":"D94","DOI":"10.1093\/nar\/gky989","article-title":"GenBank","volume":"47","author":"Sayers","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.gene.2021.145967_b0015","doi-asserted-by":"crossref","first-page":"D733","DOI":"10.1093\/nar\/gkv1189","article-title":"Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation","volume":"44","author":"O'Leary","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2021.145967_b0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K","article-title":"Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease","volume":"79","author":"Martiniuk","year":"1998","journal-title":"Am. J. Med. Genet"},{"key":"10.1016\/j.gene.2021.145967_b0025","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","article-title":"Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling","volume":"7","author":"Ausems","year":"1999","journal-title":"Eur. J. Human Genetics"},{"key":"10.1016\/j.gene.2021.145967_b0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cca.2014.01.030","article-title":"Detecting multiple lysosomal storage diseases by tandem mass spectrometry\u2014a national newborn screening program in Taiwan","volume":"431","author":"Liao","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.gene.2021.145967_b0035","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"van den Hout","year":"2003","journal-title":"Pediatrics."},{"key":"10.1016\/j.gene.2021.145967_b0040","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"Infantile-Onset Pompe Disease Natural History Study Group. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.gene.2021.145967_b0045","first-page":"132","article-title":"Biochemical, immunological, and cell genetic studies in glycogenosis type II","volume":"30","author":"Reuser","year":"1978","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2021.145967_b0050","doi-asserted-by":"crossref","unstructured":"Bali, D.S., Goldstein, J.L., Banugaria, S., Dai, J., Mackey, J., Rehder, C., Kishnani, P.S. Predicting cross\u2010reactive immunological material (CRIM) status in Pompe disease using GAA mutations: lessons learned from 10 years of clinical laboratory testing experience. 2012; 160: 40-49.10.1002\/ajmg.c.31319.","DOI":"10.1002\/ajmg.c.31319"},{"issue":"13","key":"10.1016\/j.gene.2021.145967_b0055","doi-asserted-by":"crossref","first-page":"284","DOI":"10.21037\/atm.2019.07.24","article-title":"Multisystem late onset Pompe disease (LOPD): an update on clinical aspects","volume":"7","author":"Toscano","year":"2019","journal-title":"Ann Transl Med."},{"key":"10.1016\/j.gene.2021.145967_b0060","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","article-title":"Disease severity in children and adults with Pompe disease related to age and disease duration","volume":"64","author":"Hagemans","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.gene.2021.145967_b0065","first-page":"S4","article-title":"Diagnosis of glycogenosis type II","volume":"71","author":"Bembi","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.gene.2021.145967_b0070","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/humu.23854","article-title":"Extension of the Pompe mutation database by linking disease-associated variants to clinical severity","volume":"40","author":"Ni\u00f1o","year":"2019","journal-title":"Human Mutation"},{"key":"10.1016\/j.gene.2021.145967_b0075","doi-asserted-by":"crossref","unstructured":"Deming, D., Lee, K., McSherry, T., Wei, R.R., Edmunds, T., Garman, S.C. The molecular basis for Pompe disease revealed by the structure of human acid \u03b1-glucosidase. bioRxiv 2017: 212837.10.1101\/212837.","DOI":"10.1101\/212837"},{"key":"10.1016\/j.gene.2021.145967_b0080","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/3.12.2231","article-title":"Aberrant splicing in adult-onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (\u201313T\u2192 G) mutation in a majority of patients and a novel IVS10 (1GT\u2192 CT) mutation","volume":"3","author":"Hule","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.gene.2021.145967_b0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000252798.25690.76","article-title":"Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype","volume":"68","author":"Kroos","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.gene.2021.145967_b0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genetics Med."},{"key":"10.1016\/j.gene.2021.145967_b0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.gene.2013.01.051","article-title":"Identification of the first deletion\u2013insertion involving the complete structure of GAA gene and part of CCDC40 gene mediated by an Alu element","volume":"519","author":"Ami\u00f1oso","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.gene.2021.145967_b0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","article-title":"InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines","volume":"100","author":"Li","year":"2017","journal-title":"Am J Human Genetics"},{"issue":"D1","key":"10.1016\/j.gene.2021.145967_b0105","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2021.145967_b0110","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am. J. Human Genetics"},{"key":"10.1016\/j.gene.2021.145967_b0115","doi-asserted-by":"crossref","unstructured":"Madeira, F., Park, Y.M., Lee, J., Buso, N., Gur, T., Madhusoodanan, N. et al. The EMBL-EBI search and sequence analysis tools APIs in 2019. Nucleic Acids Res. 2019; 47: W636-W641. 10.1093\/nar\/gkz268.","DOI":"10.1093\/nar\/gkz268"},{"key":"10.1016\/j.gene.2021.145967_b0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/humu.22705","article-title":"Identification and characterization of aberrant GAA Pre-mRNA splicing in pompe disease using a generic approach","volume":"36","author":"Bergsma","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.gene.2021.145967_b0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.nmd.2018.12.003","article-title":"Reevaluating the pathogenicity of the mutation c. 1194 5 G> A in GAA gene by functional analysis of RNA in a 61-year-old woman diagnosed with Pompe disease by muscle biopsy","volume":"29","author":"Ami\u00f1oso","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.gene.2021.145967_b0130","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1074\/jbc.270.6.2411","article-title":"Exon recognition in vertebrate splicing","volume":"270","author":"Berget","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2021.145967_b0135","first-page":"6299","article-title":"Effect of 5' splice site mutations on splicing of the preceding intron","volume":"10","author":"Talerico","year":"1990","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.gene.2021.145967_b0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/humu.10286","article-title":"Twenty-two novel mutations in the lysosomal \u03b1-glucosidase gene (GAA) underscore the genotype\u2013phenotype correlation in glycogen storage disease type II","volume":"23","author":"Hermans","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.gene.2021.145967_b0145","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/humu.20374","article-title":"Mutation profile of the GAA gene in 40 Italian patients with late onset glycogen storage disease type II","volume":"27","author":"Montalvo","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.gene.2021.145967_b0150","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ymgme.2007.07.006","article-title":"Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II","volume":"92","author":"McCready","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.gene.2021.145967_b0155","first-page":"3","article-title":"A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan","volume":"14","author":"Fukuhara","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.gene.2021.145967_b0160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ymgme.2007.05.011","article-title":"Glycogen storage disease type II in Spanish patients: high frequency of c. 1076\u20131G> C mutation","volume":"92","author":"Gort","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.gene.2021.145967_b0165","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s00415-015-7664-0","article-title":"Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment","volume":"262","author":"Montagnese","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.gene.2021.145967_b0170","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.nmd.2015.07.002","article-title":"Homozygosity for the common GAA gene splice site mutation c.-32-13T> G in Pompe disease is associated with the classical adult phenotypical spectrum","volume":"25","author":"Musumeci","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.gene.2021.145967_b0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12881-014-0141-2","article-title":"Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c. 2238G> C as the most common mutation","volume":"15","author":"Liu","year":"2014","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.gene.2021.145967_b0180","first-page":"311","article-title":"Three patients with glycogen storage disease type II and the mutational spectrum of GAA in Korean patients","volume":"43","author":"Park","year":"2013","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"3","key":"10.1016\/j.gene.2021.145967_b0185","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s13353-018-0444-7","article-title":"Splicing mutations in human genetic disorders: examples, detection, and confirmation","volume":"59","author":"Anna","year":"2018","journal-title":"J. Appl. Genet."},{"key":"10.1016\/j.gene.2021.145967_b0190","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-5793(01)02236-0","article-title":"The TIM-barrel fold: a versatile framework for efficient enzymes","volume":"492","author":"Wierenga","year":"2001","journal-title":"Febs Letter"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811192100562X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811192100562X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:44:54Z","timestamp":1759855494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037811192100562X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":38,"alternative-id":["S037811192100562X"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2021.145967","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic analysis of 76 Spanish Pompe disease patients: Identification of 12 novel pathogenic GAA variants and functional characterization of splicing variants","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2021.145967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"145967"}}